Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7785 results

NCT06389136

Recruiting

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up)

Atopic Dermatitis
NCT06319300

Recruiting

Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

Diabetes Type 2
NCT02137356

Unknown

Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Rectal Neoplasms
NCT00885118

Completed

4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)

Diabetes Mellitus, Type 2
NCT06680375

Completed

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

COVID-19
NCT01523496

Completed

Vitamin D Supplementation in HIV Youth

HIV Infections
NCT02134262

Unknown

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT01092325

Completed

Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure

Heart Failure
NCT01740713

Completed

Pharmacokinetic Study of Deferiprone in Paediatric Patients (DEEP-1)

Chronic Iron Overload
NCT06337032

Recruiting

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection
NCT07352800

Recruiting

Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia (HEALING)

Peripheral Arterial Occlusive Disease | Chronic Limb-Threatening Ischemia
NCT05188729

Completed

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Carcinoma | Skin Cancer | Basal Cell Carcinoma | Cancer of the Skin, Basal Cell | Cancer of the Skin
NCT05630352

Withdrawn

A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

COVID-19
NCT01906788

Unknown

The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy

Malaria Transmission
NCT06881524

Not yet recruiting

Low-Dose Amoxicillin Dual-Therapy Combined with Licorice and Lotus Root Powder Helicobacter Pylori Treatment

HELICOBACTER PYLORI INFECTIONS
NCT04041310

Active, not recruiting

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Solid Tumor, Adult
NCT01446926

Completed

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants

Pneumonia | Pneumococcal Infections | Streptococcus Pneumoniae Infections
NCT01100125

Completed

Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment

Diabetes
NCT07328854

Recruiting

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
NCT01558544

Recruiting

Cryopreservation of Ovarian Tissue

Cancer | Fertility Preservation | Risk of Premature Ovarian Failure
NCT06285799

Completed

Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

Iron-deficiency
NCT05043259

Completed

Heterologous Prime-boost Immunization with an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming with an Inactivated SARS-CoV-2 Vaccine

COVID-19
NCT05950841

Completed

Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman

Iron-deficiency
NCT03538301

Completed

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

Idiopathic Pulmonary Fibrosis
NCT04587271

Completed

Nutritional Impact of Moringa Oleifera Leaf Supplementation in Mothers and Children

Malnutrition | Wasting | Growth Failure
NCT04433949

Active, not recruiting

Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 (RESCUE1-19)

Severe Acute Respiratory Syndrome | Pneumonia | Symptomatic COVID-19 Infection Laboratory-Confirmed
NCT01968785

Terminated

Renal Denervation in Patients With Uncontrolled Blood Pressure

Blood Pressure
NCT04311294

Withdrawn

Development of a Selective ALDH2 Inhibitor to Treat AUD

Alcohol Use Disorder
NCT03461380

Completed

Effect of Menopause Relief EP-40 in Women With Menopausal Symptoms

Menopause
NCT02458352

Completed

Ultra Low Dose CT for CACS and AC of SPECT

Coronary Artery Disease
NCT01301924

Completed

Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis

Cutaneous Leishmaniasis
NCT01139437

Completed

Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants

Human Parainfluenza Virus 2
NCT07513818

Recruiting

Implementing Low-dose ct Lung Cancer Screening in France. (IMPULSION)

Lung Cancer
NCT06985615

Recruiting

A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement

Healthy Volunteers | Hepatic Impairment
NCT06835803

Recruiting

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial (ELITE-GBM)

Glioblastoma (GBM)
NCT06186934

Recruiting

Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients

Hyperphosphatemia
NCT05827939

Recruiting

Association of Phenotypic Age and Antibody Titers Among SARS-Co-V2 Infected Patients and Vaccinated Groups

COVID-19
NCT04047602

Terminated

Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study (RADREMI)

Brain Cancer | Brain Tumor | Brain Metastases
NCT06331585

Withdrawn

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Non-Small Cell Lung Cancer | Low-dose Radiotherapy | Tumor Microenvironment
NCT04645030

Completed

The Value of Ultralow Dosis CT and Ultrasound in the Diagnosing of Pneumonia in the Emergency Department

Respiratory Tract Infections
NCT02698189

Terminated

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)

DLBCL | AML Including AML de Novo and AML Secondary to MDS
NCT02106312

Unknown

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (DOREMY)

Myxoid Liposarcoma of Soft Tissue
NCT01168479

Completed

FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer (FLAME)

MRI | Prostate Cancer | Radiotherapy
NCT03181503

Completed

Safety and Efficacy of Nemolizumab in PN

Prurigo Nodularis
NCT01216995

Completed

Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI) (ADVANCE)

Acute Myocardial Infarction
NCT02254057

Completed

Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects

Healthy
NCT02203487

Completed

Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers

Healthy
NCT00001250

Completed

Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial

Neoplasm Metastasis | Breast Neoplasm
NCT05613205

Completed

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever
NCT00956111

Completed

A Clinical Trial With Influenza A/H1N1 Vaccines

Influenza

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations